Integration of miRNA and mRNA Expression Data for Understanding Etiology of Gynecologic Cancers

  • Sushmita PaulEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1912)


Dysregulation of miRNA–mRNA regulatory networks is very common phenomenon in any diseases including cancer. Altered expression of biomarkers leads to these gynecologic cancers. Therefore, understanding the underlying biological mechanisms may help in developing a robust diagnostic as well as a prognostic tool. It has been demonstrated in various studies that the pathways associated with gynecologic cancer have dysregulated miRNA as well as mRNA expression. Identification of miRNA–mRNA regulatory modules may help in understanding the mechanism of altered gynecologic cancer pathways. In this regard, an existing robust mutual information-based Maximum-Relevance Maximum-Significance algorithm has been used for identification of miRNA–mRNA regulatory modules in gynecologic cancer. A set of miRNA–mRNA modules are identified first than their association with gynecologic cancer are studied exhaustively. The effectiveness of the proposed approach is compared with the existing methods. The proposed approach is found to generate more robust integrated networks of miRNA–mRNA in gynecologic cancer.

Key words

Gynecologic cancer miRNAs Genes Mutual information MRMS Ovarian cancer Cervical cancer 



This work is partially supported by the seed grant program of the Indian Institute of Technology Jodhpur, India (grant no. I/SEED/SPU/20160010). The author wants to acknowledge Mr. Shubham Talbar, Indian Institute of Technology Jodhpur, India for his contribution in implementing certain bioinformatics tools.


  1. 1.
    Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653–4662CrossRefGoogle Scholar
  2. 2.
    American Cancer Society (n.d.) Accessed 13 June 2018
  3. 3.
    Beezhold K, Castranova V, Chen F (2010) Microprocessor of MicroRNAs: regulation and potential for therapeutic intervention. Mol Cancer 9(134). CrossRefGoogle Scholar
  4. 4.
    Bindea G, Mlecnik B, Hackl H et al (2009) ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25(8):1091CrossRefGoogle Scholar
  5. 5.
    Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23(1):175–205CrossRefGoogle Scholar
  6. 6.
    Cline MS, Craft B, Swatloski T et al (2013) Exploring TCGA Pan-Cancer data at the UCSC cancer genomics browser. Sci Rep 3(2652):1–6Google Scholar
  7. 7.
    Ding C, Peng H (2005) Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol 3(02):185–205CrossRefGoogle Scholar
  8. 8.
    Duda RO, Hart PE (1973) Pattern classification and scene analysis. Wiley, HobokenGoogle Scholar
  9. 9.
    Harfe BD (2005) MicroRNAs in vertebrate development. Curr Opin Genes Dev 15(4):410–415CrossRefGoogle Scholar
  10. 10.
    He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522–531CrossRefGoogle Scholar
  11. 11.
    Huang T, Cai YD (2013) An information-theoretic machine learning approach to expression QTL analysis. PLoS One 8(6):1–9Google Scholar
  12. 12.
    Jiang Q, Wang Y, Hao Y et al (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37:D98CrossRefGoogle Scholar
  13. 13.
    Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of MicroRNA biogenesis, function and decay. Nat Rev Genet 11:597–610CrossRefGoogle Scholar
  14. 14.
    Kutmon M, Riutta A, Nunes N et al (2016) WikiPathways: capturing the full diversity of pathway knowledge. Nucleic Acids Res 44(D1):D488CrossRefGoogle Scholar
  15. 15.
    Li J, Liu Y, Wang C et al (2015) Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma. Sci Rep 5(12921).
  16. 16.
    Maji P (2012) Mutual information-based supervised attribute clustering for microarray sample classification. IEEE Trans Knowl Data Eng 24(1):127–140CrossRefGoogle Scholar
  17. 17.
    Maji P, Paul S (2011) Rough set based maximum relevance-maximum significance criterion and gene selection from microarray data. Int J Approx Reason 52(3):408–426CrossRefGoogle Scholar
  18. 18.
    Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating MicroRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 105(30):10513–10518CrossRefGoogle Scholar
  19. 19.
    Paul S, Maji P (2016) Gene expression and protein-protein interaction data for identification of colon cancer related genes using f-information measures. Nat Comput 15(3):449–463CrossRefGoogle Scholar
  20. 20.
    Quitadamo A, Tian L, Hall B et al (2015) An integrated network of MicroRNA and gene expression in ovarian cancer. BMC Bioinf 16(5):S5CrossRefGoogle Scholar
  21. 21.
    Shabalin AA (2012) Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28(10):1353CrossRefGoogle Scholar
  22. 22.
    Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504CrossRefGoogle Scholar
  23. 23.
    Szklarczyk D, Franceschini A, Wyder S et al (2015) STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 43(D1):D447CrossRefGoogle Scholar
  24. 24.
    Yu G, Wang LG, Yan GR et al (2015) DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 31(4):608CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Bioscience & BioengineeringIndian Institute of Technology JodhpurJodhpurIndia

Personalised recommendations